In a world marked by the growth of Industry 4.0, advanced digital technologies are now emerging in drug production chains and will become competitive and operational requirements to meet tomorrow’s health challenges.
The launch and use of new drugs has traditionally been at the core of pharmaceutical companies’ marketing efforts, as the first years of commercialization provide the opportunity to take advantage of the exclusivity associated with the drug’s patent.
The government’s “My Health 2022” strategy places the improvement of the organization of care, particularly in chronic diseases, as well as the digitalization of the health system at the top of its priorities. Alcimed explored the relevance of digital solutions for the organization of care as well as the perspectives offered to healthcare stakeholders.
Avec un nombre en perpétuelle croissance de nouveaux traitements sur le marché, de régulières avancées technologiques et une multiplicité d’informations disponibles, le domaine de l’oncologie évolue à grande vitesse et modifie le parcours diagnostic-soin-observance des patients atteints de cancer.
Chez Alcimed, nous nous sommes demandés dans quelle mesure l’oncologie serait un catalyseur d’innovations dans les années à venir.
Preclinical testing is perceived as an unavoidable and problematic step in drug development, with the major disadvantage of provoking ethical controversies related to animal welfare, while not always guaranteeing relevant results for manufacturers. Although it has long seemed unavoidable, the new organ modeling technology, “Organ-on-a-chip”, now seems to be on the way to bringing about innovation to this key stage.
After several years of listening to all stakeholders in the Unmanned Aerial Vehicle (UAV) market, and a dialogue with European and American national civil aviation agencies, the European Union Aviation Safety Agency (EASA) has finally published European regulations to provide a harmonized framework for UAV operators and manufacturers in Europe.
Ultra-resistant or super-adhesive materials, survival at great depths or adaptation to amphibious life, with 3.6 billion years of R&D, the world of nature has proven that its ability to develop cutting-edge technologies. These feats, which are by their very essence respectful of their environment, have always been a source of inspiration for manufacturers. That innovative […]
At the end of 2018, the French Ministry of Solidarity and Health announced the 10 priorities of the “My health 2022” plan (in French, “Ma santé 2022”). In March 2019, Minister Agnès Buzyn declared that “among the many initiatives, digital health faces immense challenges”, starting with the transformation of training models for healthcare professionals. In […]
The 1st first 2019 healthcare-related event for our Swiss office! Many industries have been transformed by the use and development of new technologies, and this also counts for the healthcare industry. At Alcimed, we asked ourselves how the medical care of a patient would look like in the year 2050. What are your insights? To […]
Predicting what the world of healthcare will look like in 2050 is a major challenge, yet the key trends in innovation combined with certain weaker signals suggest that the patient’s condition is likely to change over the next 30 years. In order to decipher the opportunities and challenges that will come along with the transformation […]
